Woodcasting Versus Thermoplast Splint in CMC Arthroplasty

Foundation for Orthopaedic Research and Education

Status: Enrolling

Conditions: Carpometacarpal (CMC) Joint Arthritis

Treatments: Other: Control (Standard treatment); Other: Woodcasting Splint

Study type: Interventional

Funder types: Other

Identifiers

NCT06876350

Study007574

Details and patient eligibility

About

This study is a prospective, randomized, nonblinded trial to evaluate patient preference in splints after having a carpometacarpal arthroplasty.

Full description

Patients undergoing carpometacarpal arthroplasty will be randomized into the woodcast or thermoplast splint after their surgery to see which is preferred using compliance and surveys.

Enrollment: 26 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients over the age of 18 years old.
• Intact Medical Decision Making
• Eligible for Surgical Intervention
• Willing to comply with all aspects of the treatment and evaluation schedule over 6 weeks

Exclusion criteria

• Pregnant Women
• Deemed Unsuitable by Principal Investigator

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

26 participants in 2 patient groups

Woodcasting Splint

Experimental group

Description:

Woodcasting is an already FDA approved on the market product that is not used a lot so for the purpose of the study we would like to show superior outcomes.

Treatment:

Other: Woodcasting Splint

Thermoplastic Splint

Active Comparator group

Description:

Thermoplastic splints is an FDA approved on the market orthrosis that is used by Occupational Therapists which is standard of care for patients that undergo CMC arthroplasty.

Treatment:

Other: Control (Standard treatment)